Showing results (1-10 of 105) with videos related to
Sort By:
Pageof 11
Hematology/Oncology Clinics of North America|June 1, 1994
The prostate specific antigen. Its use as a tumor marker for prostate cancerP W Kantoff, J A TalcottJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes studyC J Beard, K J Propert, P P Rieker, et al.Journal of the National Cancer Institute|August 6, 1997
Patient-reported impotence and incontinence after nerve-sparing radical prostatectomyJ A Talcott, P Rieker, K J Propert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?J P Richie, P W KantoffThe Urologic Clinics of North America|June 11, 1999
Prognostic indicators in hormone refractory prostate cancerD J George, P W KantoffSeminars in Oncology|December 1, 1995
Neoadjuvant and adjuvant chemotherapy for invasive bladder cancerM R Smith, P W KantoffThe Journal of Urology|September 29, 1998
Management of hormone refractory prostate cancer: current standards and future prospectsW K Oh, P W KantoffHematology/Oncology Clinics of North America|February 1, 1992
Chemotherapy for metastatic bladder cancerP W Kantoff, H I ScherSeminars in Oncology|December 22, 1999
Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancerW K Oh, P W KantoffPageof 11